160 related articles for article (PubMed ID: 26833154)
1. Bidirectional Transfer of Raltegravir in an Ex Vivo Human Cotyledon Perfusion Model.
Vinot C; Tréluyer JM; Giraud C; Gavard L; Peytavin G; Mandelbrot L
Antimicrob Agents Chemother; 2016 May; 60(5):3112-4. PubMed ID: 26833154
[TBL] [Abstract][Full Text] [Related]
2. Placental transfer of rilpivirine in an ex vivo human cotyledon perfusion model.
Mandelbrot L; Duro D; Belissa E; Peytavin G
Antimicrob Agents Chemother; 2015 May; 59(5):2901-3. PubMed ID: 25691637
[TBL] [Abstract][Full Text] [Related]
3. Placental transfer of darunavir in an ex vivo human cotyledon perfusion model.
Mandelbrot L; Duro D; Belissa E; Peytavin G
Antimicrob Agents Chemother; 2014 Sep; 58(9):5617-20. PubMed ID: 24982090
[TBL] [Abstract][Full Text] [Related]
4. Placental transfer and tissue accumulation of dolutegravir in the ex vivo human cotyledon perfusion model.
Mandelbrot L; Ceccaldi PF; Duro D; Lê M; Pencolé L; Peytavin G
PLoS One; 2019; 14(8):e0220323. PubMed ID: 31408460
[TBL] [Abstract][Full Text] [Related]
5. Placental transfer of the HIV integrase inhibitor dolutegravir in an ex vivo human cotyledon perfusion model.
Schalkwijk S; Greupink R; Colbers AP; Wouterse AC; Verweij VG; van Drongelen J; Teulen M; van den Oetelaar D; Burger DM; Russel FG
J Antimicrob Chemother; 2016 Feb; 71(2):480-3. PubMed ID: 26538508
[TBL] [Abstract][Full Text] [Related]
6. Placental transfer of the integrase strand inhibitors cabotegravir and bictegravir in the ex-vivo human cotyledon perfusion model.
Pencolé L; Lê MP; Bouchet-Crivat F; Duro D; Peytavin G; Mandelbrot L
AIDS; 2020 Nov; 34(14):2145-2149. PubMed ID: 32796211
[TBL] [Abstract][Full Text] [Related]
7. Placental transfer of maraviroc in an ex vivo human cotyledon perfusion model and influence of ABC transporter expression.
Vinot C; Gavard L; Tréluyer JM; Manceau S; Courbon E; Scherrmann JM; Declèves X; Duro D; Peytavin G; Mandelbrot L; Giraud C
Antimicrob Agents Chemother; 2013 Mar; 57(3):1415-20. PubMed ID: 23295922
[TBL] [Abstract][Full Text] [Related]
8. Placental transfer of elvitegravir and cobicistat in an ex-vivo human cotyledon double perfusion model.
Faure-Bardon V; Mandelbrot L; Duro D; Dussaux C; Le M; Peytavin G
AIDS; 2018 Jan; 32(3):321-325. PubMed ID: 29112064
[TBL] [Abstract][Full Text] [Related]
9. Differential bidirectional transfer of indinavir in the isolated perfused human placenta.
Sudhakaran S; Ghabrial H; Nation RL; Kong DC; Gude NM; Angus PW; Rayner CR
Antimicrob Agents Chemother; 2005 Mar; 49(3):1023-8. PubMed ID: 15728898
[TBL] [Abstract][Full Text] [Related]
10. Maternal-fetal transfer of saquinavir studied in the ex vivo placental perfusion model.
Forestier F; de Renty P; Peytavin G; Dohin E; Farinotti R; Mandelbrot L
Am J Obstet Gynecol; 2001 Jul; 185(1):178-81. PubMed ID: 11483925
[TBL] [Abstract][Full Text] [Related]
11. Transplacental transfer of oseltamivir and its metabolite using the human perfused placental cotyledon model.
Berveiller P; Mir O; Vinot C; Bonati C; Duchene P; Giraud C; Gil S; Treluyer JM
Am J Obstet Gynecol; 2012 Jan; 206(1):92.e1-6. PubMed ID: 21958869
[TBL] [Abstract][Full Text] [Related]
12. Maternal-to-fetal transfer of 5-methyltetrahydrofolate by the perfused human placental cotyledon: evidence for a concentrative role by placental folate receptors in fetal folate delivery.
Henderson GI; Perez T; Schenker S; Mackins J; Antony AC
J Lab Clin Med; 1995 Aug; 126(2):184-203. PubMed ID: 7636392
[TBL] [Abstract][Full Text] [Related]
13. Is bisphenol S a safer alternative to bisphenol A in terms of potential fetal exposure ? Placental transfer across the perfused human placenta.
Grandin FC; Lacroix MZ; Gayrard V; Viguié C; Mila H; de Place A; Vayssière C; Morin M; Corbett J; Gayrard C; Gely CA; Toutain PL; Picard-Hagen N
Chemosphere; 2019 Apr; 221():471-478. PubMed ID: 30654261
[TBL] [Abstract][Full Text] [Related]
14. Contribution and limit of the model of perfused cotyledon to the study of placental transfer of drugs. Example of a protease inhibitor of HIV: nelfinavir.
Gavard L; Beghin D; Forestier F; Cayre Y; Peytavin G; Mandelbrot L; Farinotti R; Gil S
Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):157-60. PubMed ID: 19773109
[TBL] [Abstract][Full Text] [Related]
15. Transfer of inflammatory cytokines across the placenta.
Zaretsky MV; Alexander JM; Byrd W; Bawdon RE
Obstet Gynecol; 2004 Mar; 103(3):546-50. PubMed ID: 14990420
[TBL] [Abstract][Full Text] [Related]
16. Transfer of dabigatran and dabigatran etexilate mesylate across the dually perfused human placenta.
Bapat P; Kedar R; Lubetsky A; Matlow JN; Aleksa K; Berger H; Koren G
Obstet Gynecol; 2014 Jun; 123(6):1256-1261. PubMed ID: 24807346
[TBL] [Abstract][Full Text] [Related]
17. The ex vivo transfer of the anti-HIV nucleoside compound d4T in the human placenta.
Bawdon RE; Kaul S; Sobhi S
Gynecol Obstet Invest; 1994; 38(1):1-4. PubMed ID: 7959316
[TBL] [Abstract][Full Text] [Related]
18. Rivaroxaban transfer across the dually perfused isolated human placental cotyledon.
Bapat P; Pinto LS; Lubetsky A; Berger H; Koren G
Am J Obstet Gynecol; 2015 Nov; 213(5):710.e1-6. PubMed ID: 26164691
[TBL] [Abstract][Full Text] [Related]
19. Placental transfer of doravirine, a recent HIV-1 NNRTI in the ex vivo human cotyledon perfusion model.
Lê MP; Pencolé L; Peytavin G; Bouchet-Crivat F; Mandelbrot L
J Antimicrob Chemother; 2021 Aug; 76(9):2364-2367. PubMed ID: 34151361
[TBL] [Abstract][Full Text] [Related]
20. Transfer of meropenem in the ex vivo human placenta perfusion model.
Hnat M; Bawdon RE
Infect Dis Obstet Gynecol; 2005 Dec; 13(4):223-7. PubMed ID: 16338783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
